ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
|Articles|May 20, 2015
Gwen Wyatt Discusses Conducting a Multisite Randomized Trial
Author(s)Gwen Wyatt, PhD, RN, FAAN
Gwen Wyatt, PhD, RN, FAAN,discusses the challenges associated with conducting a multisite randomized clinical trial.
Advertisement
Gwen Wyatt, PhD, RN, FAAN, PhD Program Coordinator, College of Nursing, Michigan State University, discusses the challenges associated with conducting a multisite randomized clinical trial.
Advertisement
Related to this article
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced Clear Cell RCC
2
Reframing Nurse Fatigue as Systemic Safety Risk
3
FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma
4
ICN 2026: APP Leadership, Cancer Pain Care, and Nurse-Led Rapid Care Models
5